STOCK TITAN

Henry Schein Announces Participation in William Blair Emerging Technologies in Dental Care Virtual Investor Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Henry Schein, Inc. (Nasdaq: HSIC), a leading provider of health care solutions, presented at the William Blair Emerging Technologies in Dental Care Virtual Investor Conference on May 17, 2022. A replay will be accessible on their investor presentations webpage starting May 19, 2022, for up to two weeks. The company reported sales of $12.4 billion in 2021, with a 12.5% compound annual growth rate since going public in 1995. Henry Schein serves over 1 million customers globally through a network of nearly 22,000 Team Schein Members.

Positive
  • Sales reached $12.4 billion in 2021.
  • 12.5% compound annual growth rate since 1995.
Negative
  • None.

MELVILLE, N.Y.--(BUSINESS WIRE)-- Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company presented at the William Blair Emerging Technologies in Dental Care Virtual Investor Conference on May 17, 2022.

A replay of Henry Schein’s presentation will be available on the Investor Presentations section of the Henry Schein website beginning May 19, 2022, and will be available for a period of up to two weeks following the presentation.

About Henry Schein, Inc.

Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With nearly 22,000 TSMs Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites.

Henry Schein operates through a centralized and automated distribution network, with a selection of more than 120,000 branded products and Henry Schein private-brand products in stock, as well as more than 180,000 additional products available as special-order items.

A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 32 countries and territories. The Company's sales reached $12.4 billion in 2021, and have grown at a compound annual rate of approximately 12.5 percent since Henry Schein became a public company in 1995.

For more information, visit Henry Schein at www.henryschein.com, Facebook.com/HenrySchein, and @HenrySchein on Twitter.

Investors

Ronald N. South

Senior Vice President and Chief Financial Officer

ronald.south@henryschein.com

(631) 845-2802

Graham Stanley

Vice President, Investor Relations and Strategic Financial Project Officer

graham.stanley@henryschein.com

(631) 843-5963

Media

Ann Marie Gothard

Vice President, Global Corporate Media Relations

annmarie.gothard@henryschein.com

(631) 390-8169

Source: Henry Schein, Inc.

Henry Schein Inc

NASDAQ:HSIC

HSIC Rankings

HSIC Latest News

HSIC Stock Data

8.77B
123.38M
0.9%
107.44%
4.98%
Medical Distribution
Wholesale-medical, Dental & Hospital Equipment & Supplies
Link
United States of America
MELVILLE